Plasma and intracerebral pharmacokinetics and pharmacodynamics modeling for the acetylcholine releasing effect of ginsenoside Rg1 in mPFC of A β model rats

J Asian Nat Prod Res. 2021 Mar;23(3):294-306. doi: 10.1080/10286020.2020.1803289. Epub 2021 Mar 26.

Abstract

Ginsenoside Rg1 is a major bioactive component of ginseng. Limited information is available regarding Rg1 concentrations in the central neural system and the corresponding relationship of plasma/intracerebral concentrations, and intracerebral effects of Rg1. Awake Aβ model rats received a single subcutaneous administration of Rg1. Concentrations of unbound Rg1 and acetylcholine in the brain extracellular fluid and Rg1 in plasma were then determined. An Emax-two compartment pharmacokinetic/pharmacodynamics (PK/PD) model without effect compartment was finally obtained by evaluating three mechanism-based models. The corresponding relationship between the plasma PK and PD of Rg1 can be described as E = 119.05•C/(73.42 + C).[Formula: see text].

Keywords: Ginsenoside Rg1; PK/PD model; acetylcholine; microdialysis; pharmacokinetics.

MeSH terms

  • Acetylcholine*
  • Animals
  • Ginsenosides* / pharmacology
  • Molecular Structure
  • Plasma
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Ginsenosides
  • Acetylcholine
  • ginsenoside Rg1